U.S. House · 118th Congress · H.R. 1790
Biologics Competition Act of 2023
To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Mariannette Miller-MeeksR-IA-1
- Introduced
- March 24, 2023, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (4)
2 Democrats, 2 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Nanette Diaz BarragánD-CA-44
- Ann M. KusterD-NH-2
- Gregory F. MurphyR-NC-3
Signed on later
- Dan CrenshawR-TX-2April 3, 2023